Monoclonal antibodies are lab-produced molecules that can bind to specific targets on cancer cells. They can work in various ways: some mark cancer cells for destruction by the immune system, while others block growth signals or deliver cytotoxic agents directly to cancer cells. Examples include drugs like Rituximab, Trastuzumab, and Bevacizumab.